Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$342M |
| 2 |
Intercontinental Exchange
ICE
|
+$284M |
| 3 |
Deere & Co
DE
|
+$255M |
| 4 |
Blackrock
BLK
|
+$248M |
| 5 |
Newmont
NEM
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$638M |
| 2 |
Alibaba
BABA
|
+$454M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$367M |
| 4 |
Pfizer
PFE
|
+$356M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$353M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 11.43% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
201
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $297M | 0.11% |
4,803,084
-5,993,624
| -56% | -$367M |
|
202
State Street SPDR S&P Dividend ETF
SDY
$22.1B
| $296M | 0.11% |
2,804,904
+492,426
| +21% | +$49.8M |
|
203
Lyft
LYFT
$5.86B
| $295M | 0.1% |
6,001,933
+5,906,164
| +6,167% | +$215M |
|
204
Cummins
CMI
$83.6B
| $292M | 0.1% |
1,285,933
-339,116
| -21% | -$76.2M |
|
205
Duke Energy
DUK
$101B
| $291M | 0.1% |
3,174,204
+2,123,374
| +202% | +$196M |
|
206
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $290M | 0.1% |
4,299,210
+293,592
| +7% | +$19.4M |
|
207
Stryker
SYK
$135B
| $289M | 0.1% |
1,180,059
-574,678
| -33% | -$130M |
|
208
Charles River Laboratories
CRL
$11.3B
| $287M | 0.1% |
1,149,907
+388,345
| +51% | +$92.5M |
|
|
MXIM
209
DELISTED
Maxim Integrated Products
MXIM
| $285M | 0.1% |
3,211,614
-544,542
| -14% | -$43M |
|
210
CSX Corp
CSX
$94B
| $284M | 0.1% |
9,402,984
-1,766,637
| -16% | -$50.8M |
|
211
iShares Core Dividend Growth ETF
DGRO
$42.8B
| $284M | 0.1% |
6,333,893
+909,850
| +17% | +$38.7M |
|
212
Citizens Financial Group
CFG
$30.1B
| $283M | 0.1% |
7,920,359
-3,121,978
| -28% | -$98M |
|
213
Aon
AON
$80.6B
| $283M | 0.1% |
1,338,984
-286,473
| -18% | -$58.5M |
|
214
SPDR Gold Trust
GLD
$131B
| $280M | 0.1% |
1,570,209
-107,442
| -6% | -$18.9M |
|
215
Elevance Health
ELV
$81.5B
| $279M | 0.1% |
869,942
-246,365
| -22% | -$75.6M |
|
216
Boeing
BA
$169B
| $279M | 0.1% |
1,303,391
+222,639
| +21% | +$42.8M |
|
217
Carrier Global
CARR
$49.8B
| $279M | 0.1% |
7,385,572
-1,441,608
| -16% | -$52.2M |
|
218
Cerence
CRNC
$359M
| $278M | 0.1% |
2,768,603
-652,951
| -19% | -$48.7M |
|
219
iShares MSCI USA Momentum Factor ETF
MTUM
$23.6B
| $276M | 0.1% |
1,715,148
+138,128
| +9% | +$21.2M |
|
|
SPLK
220
DELISTED
Splunk Inc
SPLK
| $276M | 0.1% |
1,622,444
-266,808
| -14% | -$51M |
|
221
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.7B
| $276M | 0.1% |
3,434,052
+487,860
| +17% | +$37.6M |
|
222
Vanguard Long-Term Bond ETF
BLV
$5.74B
| $274M | 0.1% |
2,461,245
+249,341
| +11% | +$27.8M |
|
223
Dropbox
DBX
$7.78B
| $274M | 0.1% |
12,364,487
+615,890
| +5% | +$12.5M |
|
224
Nutrien
NTR
$33.9B
| $273M | 0.1% |
5,663,596
-241,966
| -4% | -$10.7M |
|
225
Sarepta Therapeutics
SRPT
$1.64B
| $272M | 0.1% |
1,597,331
+50,189
| +3% | +$7.44M |
|
Similar funds
Ameriprise's Q4 2020 Portfolio in Review
As of Q4 2020, Ameriprise held 3,918 positions worth $282B, up 15% from $246B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q4 2020 filing shows 198 new, 1,664 increased, 1,807 reduced and 165 closed positions. Its largest new stake was Array Technologies: 1,865,836 shares worth $80.5M. The largest sale was Apple, an estimated $638M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2020 buy was Array Technologies: 1,865,836 shares worth $80.5M.
- Ameriprise added most to Morgan Stanley in Q4 2020, an estimated $342M increase.
- Ameriprise's biggest Q4 2020 reduction was Apple, cutting an estimated $638M.
- Ameriprise fully exited Immunomedics Inc in Q4 2020, selling an estimated $149M.
- Ameriprise's ten largest holdings make up 16% of its $282B portfolio in Q4 2020.
- Ameriprise opened 198 new positions and closed 165 in Q4 2020.
- Ameriprise's portfolio value rose 15% quarter-over-quarter to $282B.
Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.